Theator
PrivateLast Round
Series A
Extension
Jul 22, 2022
Total Funding Raised
$66.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Theator is a healthcare technology company that provides an AI-powered surgical intelligence platform to analyze surgical video footage and generate actionable clinical insights.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theator Comparables
Compare Theator with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caresyntax | 84% | |
| Surgical Safety Technologies | 82% | |
| nSight Surgical | 81% |
Theator Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 22, 2022 | ||||
| Series A | Feb 9, 2021 | ||||
| Seed | Apr 18, 2019 |
Theator Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Seed, Series A Extension, Series A |
| StageOne Ventures | Series A Extension, Series A, Seed |
| Blumberg Capital | Series A Extension, Series A |
| Icon Ventures | Series A Extension, Series A |
| iAngels | Series A Extension, Series A, Seed |
| KdT Ventures | Series A, Seed |
| Insight Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 125% MoM, reaching 8.9K.
- Nov 8, 2025
Monthly visitors increased 35% MoM.
Theator Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theator's valuation, stock price, and market status.
Is Theator a public or private company?
Theator is a private company.
What is the current stock price of Theator?
Theator is a private company with no public stock price. No recent secondary market data is available.
How much is Theator worth (valuation)?
Valuation information for Theator is not publicly available.
Can I buy Theator stock?
Theator shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Theator's last funding round?
Theator's most recent funding round was Series A Extension on July 22, 2022.
Who are the main investors in Theator?
Key investors in Theator include StageOne Ventures, iAngels, KdT Ventures, Insight Partners.
Will Theator IPO soon?
No public IPO plans have been announced for Theator.
How can I track Theator secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theator's secondary market activity and sign up for updates.